#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	15968	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2040	766.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1404	1404	C	886	C,G	854,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	15968	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2040	766.1	0	HET	.	.	.	G395A	.	395	395	G	615	615	G	858	G,A	626,210	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29132	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3642	785.7	0	.	n	.	0	T695C	SNP	695	695	T	1151	1151	C	861	C	833	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29132	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3642	785.7	0	.	n	.	0	G1337A	SNP	1337	1337	G	1793	1793	A	938	A,G	903,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29132	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3642	785.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2427	2427	C	883	C	856	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29132	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3642	785.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2501	2501	A	904	A	872	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29132	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3642	785.7	1	SNP	n	C2597T	0	.	.	2597	2597	C	3053	3053	C	877	C	839	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	1816	folP	855	855	100.0	folP.l6.c4.ctg.1	1429	124.9	1	SNP	p	R229S	1	.	.	685	687	AGC	980	982	AGC	214;215;216	A;G;C	203;208;209	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4946	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3364	144.7	1	SNP	p	S91F	1	.	.	271	273	TTC	586	588	TTC	187;187;186	T;T,C;C	179;179,1;178	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4946	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3364	144.7	1	SNP	p	G95N	0	.	.	283	285	GGC	598	600	GGC	182;181;179	G;G,A;C	174;174,1;172	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4946	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3364	144.7	1	SNP	p	D95G	1	.	.	283	285	GGC	598	600	GGC	182;181;179	G;G,A;C	174;174,1;172	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	1652	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1351	120.3	1	SNP	p	G45D	0	.	.	133	135	GGC	436	438	GGC	203;200;200	G;G;C	195;192;191	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	780	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1044	73.8	0	.	n	.	0	A197.	DEL	197	197	A	643	643	A	184	A	173	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4870	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2822	169.4	1	SNP	p	D86N	0	.	.	256	258	GAC	529	531	GAC	204;205;208	G;A;C	195;188;197	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4870	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2822	169.4	1	SNP	p	R87W	0	.	.	259	261	CGT	532	534	CGT	209;212;214	C;G;T	199;201;197	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4870	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2822	169.4	1	SNP	p	R87I	0	.	.	259	261	CGT	532	534	CGT	209;212;214	C;G;T	199;201;197	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4870	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2822	169.4	1	SNP	p	S87R	1	.	.	259	261	CGT	532	534	CGT	209;212;214	C;G;T	199;201;197	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4870	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2822	169.4	1	SNP	p	S88P	0	.	.	262	264	TCC	535	537	TCC	211;207;209	T;C;C	200;197;198	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3922	parE	1986	1986	100.0	parE.l6.c4.ctg.1	2632	147.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1576	1578	GGC	197;194;196	G;G;C	189;184;187	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.002	penA.2.002	1	1	27	3832	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2357	159.4	1	SNP	p	A311V	0	.	.	931	933	GCA	1283	1285	GCA	238;237;241	G,T;C;A	222,1;223;230	penA.2.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3832	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2357	159.4	1	SNP	p	I312M	0	.	.	934	936	ATC	1286	1288	ATC	241;241;236	A;T;C	232;232;223	penA.2.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3832	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2357	159.4	1	SNP	p	V316T	0	.	.	946	948	GTG	1298	1300	GTG	220;216;217	G;T;G	210;204;204	penA.2.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3832	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2357	159.4	1	SNP	p	V316P	0	.	.	946	948	GTG	1298	1300	GTG	220;216;217	G;T;G	210;204;204	penA.2.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3832	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2357	159.4	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1802	1804	ACC	185;187;186	A,C;C;C	169,1;181;182	penA.2.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3832	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2357	159.4	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1856	1858	GCG	162;161;163	G;C,G;G	153;133,1;149	penA.2.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3832	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2357	159.4	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1856	1858	GCG	162;161;163	G;C,G;G	153;133,1;149	penA.2.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3832	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2357	159.4	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1979	1981	GGC	154;151;146	G;G;C	148;144;139	penA.2.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3832	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2357	159.4	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1988	1990	GGC	136;133;131	G;G;C	126;124;121	penA.2.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3832	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2357	159.4	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2006	2008	CCG	120;119;120	C,G;C,G;G,C	108,1;105,1;105,1	penA.2.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6014	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3163	187.4	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1657	1659	CCG	214;213;209	C;C;G	198;202;197	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2152	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1909	110.8	0	.	p	.	0	M83fs	FSHIFT	247	247	A	609	609	C	142	C	138	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3172	porB1b	1035	1035	98.57	porB1b.l15.c17.ctg.1	1482	210.2	0	.	p	.	0	E48G	NONSYN	142	144	GAA	437	439	GGA	243;238;244	G;G;A	234;229;230	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3172	porB1b	1035	1035	98.57	porB1b.l15.c17.ctg.1	1482	210.2	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	926	926	T	243	T	232	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3172	porB1b	1035	1035	98.57	porB1b.l15.c17.ctg.1	1482	210.2	1	SNP	p	G120K	0	.	.	358	360	GGT	653	655	GGT	250;246;242	G,A;G,A;T,G,C	239,1;239,1;228,1,1	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3172	porB1b	1035	1035	98.57	porB1b.l15.c17.ctg.1	1482	210.2	1	SNP	p	A121N	0	.	.	361	363	GCC	656	658	GCC	240;241;241	G,A;C,A;C	235,1;234,1;236	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3172	porB1b	1035	1035	98.57	porB1b.l15.c17.ctg.1	1482	210.2	1	SNP	p	A121D	0	.	.	361	363	GCC	656	658	GCC	240;241;241	G,A;C,A;C	235,1;234,1;236	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11016	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4699	230.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1198	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1168	101.0	1	SNP	p	V57M	1	.	.	169	171	ATG	570	572	ATG	243;247;246	A;T;G	234;239;238	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
